Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
Zhongya Chen,1,2 Jiaxin Deng,1,2 Yan Zhao,1,2 Tao Tao1,21National Pharmaceutical Engineering Research Center, 2Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of ChinaBackground: Integrins αv&a...
Enregistré dans:
Auteurs principaux: | Chen Z, Deng J, Zhao Y, Tao T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/15b20fa854d14fa7a54d4d31e24e52d9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
par: Song Z, et autres
Publié: (2017) -
Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
par: Li C, et autres
Publié: (2013) -
Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery
par: Lim C, et autres
Publié: (2018) -
Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation
par: Kang MJ, et autres
Publié: (2013) -
Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake
par: Li X, et autres
Publié: (2011)